The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 04, 2014
Filed:
Mar. 28, 2011
Applicants:
Yuuki Takaishi, Tokyo, JP;
Soichiro Nakamura, Tokyo, JP;
Inventors:
Yuuki Takaishi, Tokyo, JP;
Soichiro Nakamura, Tokyo, JP;
Assignee:
Astellas Pharma Inc., Tokyo, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/426 (2006.01); A61P 13/10 (2006.01); A61P 1/00 (2006.01); A61P 3/04 (2006.01); A61P 3/06 (2006.01); A61P 3/00 (2006.01); A61P 13/00 (2006.01); A61K 9/00 (2006.01); A61P 3/10 (2006.01); A61K 9/20 (2006.01); A61K 9/28 (2006.01);
U.S. Cl.
CPC ...
A61K 9/2031 (2013.01); A61K 9/0004 (2013.01); A61K 9/2086 (2013.01); A61K 31/426 (2013.01); A61K 9/205 (2013.01); A61K 9/2846 (2013.01); A61K 9/2054 (2013.01);
Abstract
A pharmaceutical composition for modified release comprising (R)-2-(2-aminothiazol-4-yl)-4'-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]acetic acid anilide or a pharmaceutically acceptable salt thereof, and a carrier for a sustained release pharmaceutical composition, wherein a dissolution rate of the drug from the composition is less than 85% after 30 minutes from the beginning of a dissolution test, is disclosed.